Effect of anti-histamine and oral corticosteroid for symptoms in oral food challenge

Effect of anti-histamine and oral corticosteroid for symptoms in oral food challenge - Anti-histamine and oral corticosteroid for symptoms in OFC

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000033584

Enrollment

Registered

2018-08-02

Start date

2018-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

food allergy

Interventions

Anti-histamine only Oral corticosteroid only Both anti-histamine and oral corticosteroid

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients 1) who underwent inpatient OFC 2) who are 5 years old or older 3) who have abdominal pain when diagnosed as positive in OFC.

Exclusion criteria

Exclusion criteria: Patients who require adrenaline administration in time of randomization.

Design outcomes

Primary

Measure	Time frame
Duration of abdominal pain (Assessed with Wong-Baker FACES Pain Rating Scale at least every 5 minutes)	—

Secondary

Measure	Time frame
- Additional treatment (antihistamine, corticosteroid, adrenaline, Inhaled beta2-agonists) - Duration of other symptoms	—

Countries

Japan

Contacts

Public ContactKyohei Takahashi

National Hospital Organizaion Sagamihara Hospital Department of Pediatrics

kcrt@kcrt.net042-742-8311

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026